Outset Medical, Inc.
OM
$4.56
$0.122.70%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -6.33% | 5.60% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.33% | 5.60% | |||
| Cost of Revenue | -8.75% | 4.63% | |||
| Gross Profit | -2.33% | 7.24% | |||
| SG&A Expenses | -6.04% | 6.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.30% | 4.60% | |||
| Operating Income | 6.24% | -2.79% | |||
| Income Before Tax | 5.44% | 28.17% | |||
| Income Tax Expenses | 288.46% | -9.57% | |||
| Earnings from Continuing Operations | 3.79% | 28.09% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.79% | 28.09% | |||
| EBIT | 6.24% | -2.79% | |||
| EBITDA | 5.78% | -3.95% | |||
| EPS Basic | 4.01% | 71.47% | |||
| Normalized Basic EPS | 5.65% | 59.35% | |||
| EPS Diluted | 4.01% | 71.47% | |||
| Normalized Diluted EPS | 5.65% | 59.35% | |||
| Average Basic Shares Outstanding | 0.23% | 152.10% | |||
| Average Diluted Shares Outstanding | 0.23% | 152.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||